WILMINGTON, DELAWARE--(Marketwire - September 09, 2009) - Global Biotech Corp (OTCBB: GBIQ) is a publicly traded company with interests in the retail phytochemical, nutraceutical, cosmeceutical and pharmaceutical areas. Global owns the trademarked product Aquaboost, oxygenated spring water www.aquaboost.com.
Today some of the most successful pharmaceutical and nutraceutical products are derived from plant cell lines. Based on their proven success in this area, the Helios Group of Italy has commenced negotiations with Global Biotech and Pharmateck Canada which will see Helios’ phyto cell line make its way onto the North American markets.
“This partnership will take Helios Group’s expertise to a new Continent. We are excited that Global Biotech Corp. will manufacture and market the phyto- cell lines to select Canadian and US customers”, said Louis Greco, Global’s President.
“The solid growth of our company’s brands mirror the great response we’ve had from our customers with their continued demand for our phytochemicals”, stated a spokesman for the Helios Group.
About: Global Biotech Corp. is dedicated to investigating and developing Green technology platforms to conserve our natural resources. The Global is positioning its AquaBoost™ product as a top quality oxygenated water due to its unique oxygenation level (up to 100 p.p.m. and greater), ability to retain this level of oxygenation over lengthy periods of time and the purity of the product. The Company is also in the process of developing other naturally oxygenated beverages and fruit juices.
About: Helios Group (Italy) is an Italian Biotechnology corp. One of their companies specializes in producing phytochemical products for nutraceutical and pharmaceutical usage, based on plant cell line cultures.
Forward-Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainties, which may include statements about business strategy and development plans, plans for entering into new business, anticipated sources of funds, including the proceeds from future operations, and plans, objectives, expectations and intentions contained in this Press Release that are not historical facts. When used in this Press Release, the words “expects,” “intends,” “projects,” “plans,” “believes,” “seeks,” “estimates” and similar expressions are generally intended to identify forward-looking statements. Because these forward-looking statements involve risk and uncertainties, actual results could differ materially from those discussed in this Press Release. These risks are outlined in our SEC filings.
Contacts:
Global Biotech Corp.
Louis Greco
President
514-333-4545
louisgreco@globalbiotechcorp.com
www.globalbiotechcorp.com